Adcetris (brentuximab vedotin)

pCPA File Number: 21264
Negotiation Status:
Concluded with an LOI
Indication(s):
Peripheral T-cell Lymphoma (PTCL)
Sponsor/Manufacturer:
Seattle Genetics Inc.
CDA-AMC Project Number:
pCODR 10199
pCPA Engagement Letter Issued:
Negotiation Process Concluded: